Leonard Sank - Jul 28, 2022 Form 4 Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role
Director
Signature
/s/Leonard Sank
Stock symbol
ORMP
Transactions as of
Jul 28, 2022
Transactions value $
$0
Form type
4
Date filed
8/1/2022, 08:00 PM
Previous filing
Jan 5, 2022
Next filing
Aug 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORMP Common Stock Award +12K +200% 18K Jul 28, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 4,000 shall vest on each of January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.
F2 The reporting person previously reported and disclaimed beneficial ownership over 138,889 shares of common stock owned by a company wholly owned by a trust of which the reporting person was previously a trustee. The reporting person resigned as a trustee of such trust, effective February 3, 2022.